Indications for Omega-3 Long Chain Polyunsaturated Fatty Acid in the Prevention and Treatment of Cardiovascular Disease

Paul Nestel, Peter Clifton, David Colquhoun, Manny Noakes, Trevor A. Mori, David Sullivan, Beth Thomas

Research output: Contribution to journalReview article

85 Citations (Scopus)

Abstract

Background: The National Heart Foundation of Australia (NHFA) 2008 review on omega-3 long-chain polyunsaturated fatty acids (LCPUFA) made recommendations with respect to supplementation for primary and secondary prevention of cardiovascular disease. Since then, new findings have been published regarding the relationship between omega-3 polyunsaturated fatty acids, including supplementation, and cardiovascular health. Methods: A literature search was undertaken in PubMed and Medline, for literature published between January 1, 2007 and August 31, 2013. Results and Conclusions: A total of eight research questions were developed and, using the National Health and Medical Research Council's evidence assessment framework, conclusions were made in relation to dietary intake of fish and omega-3 LCPUFA for cardiovascular health. In the evidence published since 2007, this summary of evidence concludes that dietary intake of fish was found to be mostly consistent with respect to protection from heart disease and stroke. Higher fish intake was associated with lower incident rates of heart failure in addition to lower sudden cardiac death, stroke and myocardial infarction. In relation to omega-3 LCPUFA supplementation, neither a beneficial nor adverse effect was demonstrated in primary or secondary prevention of coronary heart disease (CHD). Although the evidence continues to be positive for the role of omega-3 LCPUFA in the treatment of hypertriglyceridaemia and a modest positive benefit in heart failure. No further evidence was found to support the consumption of 2. g alpha-linolenic acid (ALA)/day over the current Australian guidelines for 1. g/day.

LanguageEnglish
Pages769-779
Number of pages11
JournalHeart Lung and Circulation
Volume24
Issue number8
DOIs
Publication statusPublished - 1 Aug 2015

Keywords

  • Cardiovascular disease
  • Fish consumption
  • Fish oil
  • Omega-3 polyunsaturated fatty acid supplements
  • Recent evidence

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Nestel, Paul ; Clifton, Peter ; Colquhoun, David ; Noakes, Manny ; Mori, Trevor A. ; Sullivan, David ; Thomas, Beth. / Indications for Omega-3 Long Chain Polyunsaturated Fatty Acid in the Prevention and Treatment of Cardiovascular Disease. In: Heart Lung and Circulation. 2015 ; Vol. 24, No. 8. pp. 769-779.
@article{1da4dd96335b462d8e4b8812935b32ce,
title = "Indications for Omega-3 Long Chain Polyunsaturated Fatty Acid in the Prevention and Treatment of Cardiovascular Disease",
abstract = "Background: The National Heart Foundation of Australia (NHFA) 2008 review on omega-3 long-chain polyunsaturated fatty acids (LCPUFA) made recommendations with respect to supplementation for primary and secondary prevention of cardiovascular disease. Since then, new findings have been published regarding the relationship between omega-3 polyunsaturated fatty acids, including supplementation, and cardiovascular health. Methods: A literature search was undertaken in PubMed and Medline, for literature published between January 1, 2007 and August 31, 2013. Results and Conclusions: A total of eight research questions were developed and, using the National Health and Medical Research Council's evidence assessment framework, conclusions were made in relation to dietary intake of fish and omega-3 LCPUFA for cardiovascular health. In the evidence published since 2007, this summary of evidence concludes that dietary intake of fish was found to be mostly consistent with respect to protection from heart disease and stroke. Higher fish intake was associated with lower incident rates of heart failure in addition to lower sudden cardiac death, stroke and myocardial infarction. In relation to omega-3 LCPUFA supplementation, neither a beneficial nor adverse effect was demonstrated in primary or secondary prevention of coronary heart disease (CHD). Although the evidence continues to be positive for the role of omega-3 LCPUFA in the treatment of hypertriglyceridaemia and a modest positive benefit in heart failure. No further evidence was found to support the consumption of 2. g alpha-linolenic acid (ALA)/day over the current Australian guidelines for 1. g/day.",
keywords = "Cardiovascular disease, Fish consumption, Fish oil, Omega-3 polyunsaturated fatty acid supplements, Recent evidence",
author = "Paul Nestel and Peter Clifton and David Colquhoun and Manny Noakes and Mori, {Trevor A.} and David Sullivan and Beth Thomas",
year = "2015",
month = "8",
day = "1",
doi = "10.1016/j.hlc.2015.03.020",
language = "English",
volume = "24",
pages = "769--779",
journal = "Heart, lung & circulation",
issn = "1443-9506",
publisher = "Wiley-Blackwell",
number = "8",

}

Indications for Omega-3 Long Chain Polyunsaturated Fatty Acid in the Prevention and Treatment of Cardiovascular Disease. / Nestel, Paul; Clifton, Peter; Colquhoun, David; Noakes, Manny; Mori, Trevor A.; Sullivan, David; Thomas, Beth.

In: Heart Lung and Circulation, Vol. 24, No. 8, 01.08.2015, p. 769-779.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Indications for Omega-3 Long Chain Polyunsaturated Fatty Acid in the Prevention and Treatment of Cardiovascular Disease

AU - Nestel, Paul

AU - Clifton, Peter

AU - Colquhoun, David

AU - Noakes, Manny

AU - Mori, Trevor A.

AU - Sullivan, David

AU - Thomas, Beth

PY - 2015/8/1

Y1 - 2015/8/1

N2 - Background: The National Heart Foundation of Australia (NHFA) 2008 review on omega-3 long-chain polyunsaturated fatty acids (LCPUFA) made recommendations with respect to supplementation for primary and secondary prevention of cardiovascular disease. Since then, new findings have been published regarding the relationship between omega-3 polyunsaturated fatty acids, including supplementation, and cardiovascular health. Methods: A literature search was undertaken in PubMed and Medline, for literature published between January 1, 2007 and August 31, 2013. Results and Conclusions: A total of eight research questions were developed and, using the National Health and Medical Research Council's evidence assessment framework, conclusions were made in relation to dietary intake of fish and omega-3 LCPUFA for cardiovascular health. In the evidence published since 2007, this summary of evidence concludes that dietary intake of fish was found to be mostly consistent with respect to protection from heart disease and stroke. Higher fish intake was associated with lower incident rates of heart failure in addition to lower sudden cardiac death, stroke and myocardial infarction. In relation to omega-3 LCPUFA supplementation, neither a beneficial nor adverse effect was demonstrated in primary or secondary prevention of coronary heart disease (CHD). Although the evidence continues to be positive for the role of omega-3 LCPUFA in the treatment of hypertriglyceridaemia and a modest positive benefit in heart failure. No further evidence was found to support the consumption of 2. g alpha-linolenic acid (ALA)/day over the current Australian guidelines for 1. g/day.

AB - Background: The National Heart Foundation of Australia (NHFA) 2008 review on omega-3 long-chain polyunsaturated fatty acids (LCPUFA) made recommendations with respect to supplementation for primary and secondary prevention of cardiovascular disease. Since then, new findings have been published regarding the relationship between omega-3 polyunsaturated fatty acids, including supplementation, and cardiovascular health. Methods: A literature search was undertaken in PubMed and Medline, for literature published between January 1, 2007 and August 31, 2013. Results and Conclusions: A total of eight research questions were developed and, using the National Health and Medical Research Council's evidence assessment framework, conclusions were made in relation to dietary intake of fish and omega-3 LCPUFA for cardiovascular health. In the evidence published since 2007, this summary of evidence concludes that dietary intake of fish was found to be mostly consistent with respect to protection from heart disease and stroke. Higher fish intake was associated with lower incident rates of heart failure in addition to lower sudden cardiac death, stroke and myocardial infarction. In relation to omega-3 LCPUFA supplementation, neither a beneficial nor adverse effect was demonstrated in primary or secondary prevention of coronary heart disease (CHD). Although the evidence continues to be positive for the role of omega-3 LCPUFA in the treatment of hypertriglyceridaemia and a modest positive benefit in heart failure. No further evidence was found to support the consumption of 2. g alpha-linolenic acid (ALA)/day over the current Australian guidelines for 1. g/day.

KW - Cardiovascular disease

KW - Fish consumption

KW - Fish oil

KW - Omega-3 polyunsaturated fatty acid supplements

KW - Recent evidence

UR - http://www.scopus.com/inward/record.url?scp=84938090122&partnerID=8YFLogxK

U2 - 10.1016/j.hlc.2015.03.020

DO - 10.1016/j.hlc.2015.03.020

M3 - Review article

VL - 24

SP - 769

EP - 779

JO - Heart, lung & circulation

T2 - Heart, lung & circulation

JF - Heart, lung & circulation

SN - 1443-9506

IS - 8

ER -